USPTO trademark

VIEWPOINT BIOPHARMA

Under examinationUSPTOWord markClass 1Class 5Class 42

"VIEWPOINT BIOPHARMA" is a word mark owned by Perspective Therapeutics, Inc., filed at the USPTO on July 10, 2026. It is under examination and covers classes 1, 5 and 42.

View Perspective Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
VIEWPOINT BIOPHARMA trademark as filed
As filed with the USPTO
Status
Under examination
Since July 10, 2026
Filed
July 10, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99933476
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns VIEWPOINT BIOPHARMA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Perspective Therapeutics, Inc.

CATX · Seattle, United States

9 trademarks in the portfolioView company

Representative

Sandra L Etherton

Etherton Law Group, LLC

Goods and services

What the mark covers

The products and services VIEWPOINT BIOPHARMA is filed for, grouped by Nice class.

  • Radiopharmaceutical chemical compounds; radiolabeled chemical compounds comprising alpha-emitting radionuclides; bifunctional chelating agents for conjugating radionuclides to targeting molecules; chemical precursors for use in the manufacture of radiopharmaceuticals; chelating compounds for radiolabeling of peptides and small molecules; radioactive isotope-labeled chemical intermediates for pharmaceutical research and manufacturing

  • Radiopharmaceutical preparations; Radiopharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations for the diagnosis of cancer; targeted alpha therapy radiopharmaceutical preparations for the treatment of cancer; radioligand therapy preparations comprising radiolabeled targeting compounds for oncological use; radiopharmaceutical diagnostic agents for use in nuclear medicine imaging; radiopharmaceutical preparations for the treatment of cancers; radiolabeled peptide conjugates for use in cancer therapy; radiopharmaceutical preparations for theranostic applications in oncology

  • nuclear medicine; contract research services in the field of radiopharmaceutical drug discovery and development; preclinical research and development services relating to radiolabeled compounds for cancer therapy and diagnosis; scientific consultation services in the field of targeted radionuclide therapy; laboratory research services in the field of radiochemistry and radiopharmaceutical development; drug discovery research services in the field of oncology radiopharmaceuticals; scientific and technological services relating to the development of radiolabeled targeted alpha therapy compounds; research and development services relating to theranostic radiopharmaceutical platforms

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. New application office supplied data entered
  2. Application filing receipt mailed
  3. New application entered
FAQ

About VIEWPOINT BIOPHARMA

Who owns the trademark "VIEWPOINT BIOPHARMA"?

The USPTO trademark "VIEWPOINT BIOPHARMA" (application 99933476) is owned by Perspective Therapeutics, Inc.

What is the status of "VIEWPOINT BIOPHARMA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VIEWPOINT BIOPHARMA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019f5160-3d9c-766d-bacb-d6d3fbed42f8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f5160-3d9c-766d-bacb-d6d3fbed42f8",
  "object": "trademark",
  "mark_text": "VIEWPOINT BIOPHARMA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99933476",
  "filing_date": "2026-07-10",
  "nice_classes": [
    1,
    5,
    42
  ],
  "owners": [
    {
      "name": "Perspective Therapeutics, Inc.",
      "entity_id": "ent_019eb71e-ff8e-77cb-847f-405458050095"
    }
  ]
}